Figure 3.
Impact of ERT on changes on plasma chitotriosidase activity. (A) Plasma chitotriosidase at baseline and after 12 months, (B) time to reach a chitotriosidase of less than 5000 nmol/mL/h. Chitotriosidase levels of carriers of the chitotriosidase null mutation were multiplied by 2.29